Key result
Patients aged ≥80 years undergoing elective complex high-risk percutaneous interventions had the highest in-hospital mortality, bleeding events, and MACCE.
Why the study?
Should complex high-risk percutaneous coronary interventions be offered to selected octogenarians and nonagenarians?
Observational (n=424,290)
Should complex high-risk percutaneous coronary interventions be offered to selected octogenarians and nonagenarians?
Despite higher risks of mortality and complications, complex high-risk PCI can be offered to carefully selected octogenarians and nonagenarians when benefits outweigh risks.
Answers are grounded in this paper and cite their sources.
Elevated risks in octogenarian CHiP patients warrant cautious selection; leaves open optimal criteria for prospective trials.
Key Points Between 2009 and 2017 23.4% of 424,290 elective complex high‐risk percutaneous interventions (CHiP) were performed in patients aged ≥80 years. Octogenarians had the highest in hospital mortality, bleeding events and major adverse cardiovascular and cerebrovascular events. CHiP can and should be offered to ≥80‐year‐old patients when the potential benefits outweigh the risks. Careful procedural planning and meticulous execution are important for optimizing the outcomes of CHiP in ≥80‐year‐old patients.
No takes yet. Share an insight, caveat, or question.
Allana et al. (2022) conducted an observational in Elective complex high-risk percutaneous interventions (CHiP) (n=424,290). Complex high-risk percutaneous interventions (CHiP) in octogenarians/nonagenarians vs. Younger patients was evaluated on In-hospital mortality, bleeding events, and major adverse cardiovascular and cerebrovascular events. Patients aged ≥80 years undergoing elective complex high-risk percutaneous interventions had the highest in-hospital mortality, bleeding events, and MACCE.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: